Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short term Debt (2018 - 2019)

Sunshine Biopharma (SBFM) has disclosed Short term Debt for 2 consecutive years, with $27541.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Short term Debt changed N/A year-over-year to $27541.0, compared with a TTM value of $27541.0 through Sep 2019, changed N/A, and an annual FY2018 reading of $20871.0, changed N/A over the prior year.
  • Short term Debt was $27541.0 for Q3 2019 at Sunshine Biopharma, down from $27869.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $59558.0 in Q1 2019 and bottomed at $20871.0 in Q4 2018.